Angiographic diagnosis of mesenteric arterial vasoconstriction

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Experimental mesenteric arterial vasoconstriction (MAV) is characterized by narrowings at the origins of multiple branches of the superior mesenteric artery, irregularities in intestinal branches, spasm of arcades, and impaired filling of intramural vessels. None of these findings occurred in a control group of patients without MAV. MAV may be diffuse or localized and reversible or irreversible. Reversible MAV decreases after test infusion of papaverine, and responds to therapeutic infusion of 30-60 mg of papaverine per hr for 16 to 24 hr. Several case studies are presented. Early diagnosis of reversible MAV is important to prevent irreversible bowel changes.

Original languageEnglish (US)
Pages (from-to)533-542
Number of pages10
JournalRadiology
Volume112
Issue number3
StatePublished - 1974

Fingerprint

Vasoconstriction
Papaverine
Superior Mesenteric Artery
Spasm
Early Diagnosis
Control Groups
Therapeutics

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Angiographic diagnosis of mesenteric arterial vasoconstriction. / Siegelman, S. S.; Sprayregen, Seymour; Boley, Scott J.

In: Radiology, Vol. 112, No. 3, 1974, p. 533-542.

Research output: Contribution to journalArticle

@article{435462e31fc946c08b2ef84445e9e0ee,
title = "Angiographic diagnosis of mesenteric arterial vasoconstriction",
abstract = "Experimental mesenteric arterial vasoconstriction (MAV) is characterized by narrowings at the origins of multiple branches of the superior mesenteric artery, irregularities in intestinal branches, spasm of arcades, and impaired filling of intramural vessels. None of these findings occurred in a control group of patients without MAV. MAV may be diffuse or localized and reversible or irreversible. Reversible MAV decreases after test infusion of papaverine, and responds to therapeutic infusion of 30-60 mg of papaverine per hr for 16 to 24 hr. Several case studies are presented. Early diagnosis of reversible MAV is important to prevent irreversible bowel changes.",
author = "Siegelman, {S. S.} and Seymour Sprayregen and Boley, {Scott J.}",
year = "1974",
language = "English (US)",
volume = "112",
pages = "533--542",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "3",

}

TY - JOUR

T1 - Angiographic diagnosis of mesenteric arterial vasoconstriction

AU - Siegelman, S. S.

AU - Sprayregen, Seymour

AU - Boley, Scott J.

PY - 1974

Y1 - 1974

N2 - Experimental mesenteric arterial vasoconstriction (MAV) is characterized by narrowings at the origins of multiple branches of the superior mesenteric artery, irregularities in intestinal branches, spasm of arcades, and impaired filling of intramural vessels. None of these findings occurred in a control group of patients without MAV. MAV may be diffuse or localized and reversible or irreversible. Reversible MAV decreases after test infusion of papaverine, and responds to therapeutic infusion of 30-60 mg of papaverine per hr for 16 to 24 hr. Several case studies are presented. Early diagnosis of reversible MAV is important to prevent irreversible bowel changes.

AB - Experimental mesenteric arterial vasoconstriction (MAV) is characterized by narrowings at the origins of multiple branches of the superior mesenteric artery, irregularities in intestinal branches, spasm of arcades, and impaired filling of intramural vessels. None of these findings occurred in a control group of patients without MAV. MAV may be diffuse or localized and reversible or irreversible. Reversible MAV decreases after test infusion of papaverine, and responds to therapeutic infusion of 30-60 mg of papaverine per hr for 16 to 24 hr. Several case studies are presented. Early diagnosis of reversible MAV is important to prevent irreversible bowel changes.

UR - http://www.scopus.com/inward/record.url?scp=0016242089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016242089&partnerID=8YFLogxK

M3 - Article

C2 - 4843282

AN - SCOPUS:0016242089

VL - 112

SP - 533

EP - 542

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 3

ER -